Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ABIO

ARCA biopharma, Inc is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate, Gencaroâ„¢ (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that is in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and left ventricular systolic dysfunction, or HFREF.
Primary Exchange: NASDAQ
SIC In Vitro & In Vivo Diagnostic Substances
NAICS In-Vitro Diagnostic Substance Manufacturing

ABIO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.5 B 1.554E+10 3,423 3423 0.0% 0 580 580
WMCR Invesco Wilshire Micro-Cap ETF 26.3 M 2.63E+07 1,083 1083 0.01% 7E-05 2 K 1853

Wait, Before You Leave...